middle.news
PYC Therapeutics Advances PKD Drug with Phase 1b Trial
9:26am on Thursday 7th of May, 2026 AEST
•
Biotechnology
Read Story
PYC Therapeutics Advances PKD Drug with Phase 1b Trial
9:26am on Thursday 7th of May, 2026 AEST
Key Points
Phase 1b Multiple Ascending Dose trial initiated
First PKD patient dosed with PYC-003
Study to assess safety, tolerability, and biomarkers
Phase 1a data expected in second half 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PYC Therapeutics (ASX:PYC)
OPEN ARTICLE